FIELD: medicine.
SUBSTANCE: oral pharmaceutical preparation in the form of a film-coated tablet contains substances in the following proportions, wt %: moxifloxacin 50.0-72.5; potatoe starch 5.0-20.0; polividone 1.0-5.0; calcium stearate 0.5-2.5; hydroxypropylmethylcellulose - the rest; the coating represents a film in the following proportions, wt %: dying agent - 0.0001-0.05; macrogol 4000 5.0-20.0; titanium dioxide 10.0-15.0; hydroxypropylmethylcellulose - the rest.
EFFECT: preparation improvement.
2 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| MATRIX TABLET WITH TRIMETAZIDINE PROLONGED-RELEASE BASE AND METHOD FOR PREPARING IT | 2010 |
|
RU2445958C2 |
| SOLID DOSAGE FORM OF AZITHROMYCIN | 2012 |
|
RU2498805C1 |
| ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
| MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
| TABLETS OF CLOZAPINE WITH SUSTAINED RELEASE | 2016 |
|
RU2613192C1 |
| FORMULATION OF COMBINED PHARMACEUTICAL CHONDROPROTECTIVE DRUG | 2010 |
|
RU2432166C1 |
| PHARMACEUTICAL FORMULATION OF PROLONGED ACTION WITH DIURETIC, VASODILATATION AND HYPOTENSIVE ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2286150C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE | 2021 |
|
RU2798106C1 |
